title: Does papaverine interact with levodopa in Parkinson's disease?
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: O
authors.initials: O
authors.lastname: Rascol
authors.forename: J
authors.initials: J
authors.lastname: Belin
authors.forename: M
authors.initials: M
authors.lastname: Ane
authors.forename: A
authors.initials: A
authors.lastname: Rascol
mesh_terms: D000368:Aged; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007980:Levodopa / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000494:pharmacology* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011897:Random Allocation
chemical_list: D007980:Levodopa; D010208:Papaverine